Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

NCT00036088 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00036088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00036088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2001
Completion date
July 31, 2002
Enrollment
530
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia